H35.3
Degeneration of macula and posterior pole
Clinical Classification Guidelines
Medical Intelligence & Overview
Degeneration of the macula and posterior pole is a condition that affects the central part of the retina in the eye, known as the macula. The macula is responsible for sharp central vision, which is needed for activities like reading, driving, and recognizing faces. When degeneration occurs in this area, it can lead to a gradual loss of clear central vision, impacting daily life. This condition is most commonly associated with age-related changes but can also arise from other factors.
Causes & Symptoms
Clinical Causes: Age-related macular degeneration (AMD), the most common cause, especially in people over 50. Genetic predisposition, where family history increases risk. Environmental factors such as smoking and prolonged exposure to sunlight without protection. Other health conditions, including cardiovascular disease and high blood pressure. Diet lacking in antioxidants and nutrients essential for eye health. Inflammatory or infectious eye diseases that damage the retinal tissue. Use of certain medications that may affect the retina.
Key Symptoms: Gradual loss of central vision, making it difficult to see fine details. Straight lines appearing wavy or distorted (metamorphopsia). Difficulty recognizing faces or reading small print. A blurry or dark area in the central vision field. Continued vision decline over time without pain. Possible perception of color changes in the central visual field.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye examination, which may include visual acuity tests, dilated eye exams, and imaging techniques like optical coherence tomography (OCT) and fluorescein angiography. These tools help eye care professionals assess the retina's condition, identify the extent of degeneration, and determine the appropriate management plan.
Treatment Protocols: While there is currently no cure for macular degeneration, several strategies can help slow its progression and manage symptoms. Treatment options include pharmacological therapies like anti-vascular endothelial growth factor (anti-VEGF) injections for wet AMD, nutritional supplements rich in antioxidants and zinc, and lifestyle modifications such as quitting smoking and protecting eyes from UV light. Additionally, assistive devices like magnifiers and specialized glasses can aid vision.
Clinical Advice & FAQs
Billing Guidance
Is H35.3 a billable ICD-10 code?
Yes, H35.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H35.3?
Clinical documentation must specify the nature of Degeneration of macula and posterior pole and any associated comorbidities for accurate reporting.
Cite this Clinical Reference